Lv2
146 积分 2025-09-21 加入
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
12天前
已完结
Impact of gene mutations on survival with azacitidine or conventional care regimens (CCR) in older patients with acute myeloid leukemia
14天前
已完结
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion
14天前
已完结
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion
18天前
已完结
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study
20天前
已完结
Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylation
1个月前
已完结
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
2个月前
已完结
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
2个月前
已完结
Sonrotoclax: First Approval
3个月前
已完结
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
3个月前
已完结
皖公网安备34019202002308
